| Biomarker ID | 1855 |
| PMID | 30345533 |
| Year | 2018 |
| Biomarker | miR-572 |
| Biomarker Basis | Expression Based |
| Biomolecule | miRNA |
| Source | Tissue |
| Subjects | Humans |
| Regulation | Upregulated in PCa |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | Pathway include: homophilic cell adhesion via plasma membrane adhesion molecules; cell-cell adhesion via plasma-membrane adhesion molecules; sequence-specific DNA binding; DNA-binding transcription factor activity; DNA-binding transcription factor activity, RNA polymerase II-specific |
| Experiment | Biochemical Recurrence Vs No Biochemical Recurrence |
| Type of Biomarker | Prognostic |
| Cohort | 40 paitents with recurrence and 39 with no recurrence were selected for this study |
| Senstivity | NA |
| Specificity | NA |
| AUC | 0.611 |
| Accuracy | NA |
| Level Of Significance | p= 0.031 |
| Method Used | qRT-PCR |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Not validated on independent patient dataset |
| Technical Name | NA |